Global Point-Of-Care Or Rapid Diagnostics Market Analysis and Forecast 2024-2030

Global Point-Of-Care Or Rapid Diagnostics Market Analysis and Forecast 2024-2030


Summary

According to APO Research, The global Point-Of-Care Or Rapid Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Point-Of-Care Or Rapid Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Point-Of-Care Or Rapid Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Point-Of-Care Or Rapid Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Point-Of-Care Or Rapid Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Point-Of-Care Or Rapid Diagnostics include Roche, Abbott, Danaher, Siemens Healthcare, Bio-Rad Laboratories, BioMerieux, Nova Biomedical, Thermo Fisher Scientific and Quidel, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Point-Of-Care Or Rapid Diagnostics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Point-Of-Care Or Rapid Diagnostics, also provides the sales of main regions and countries. Of the upcoming market potential for Point-Of-Care Or Rapid Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Point-Of-Care Or Rapid Diagnostics sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Point-Of-Care Or Rapid Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Point-Of-Care Or Rapid Diagnostics sales, projected growth trends, production technology, application and end-user industry.

Point-Of-Care Or Rapid Diagnostics segment by Company

Roche
Abbott
Danaher
Siemens Healthcare
Bio-Rad Laboratories
BioMerieux
Nova Biomedical
Thermo Fisher Scientific
Quidel
A. Menarini Diagnostics
Becton Dickinson
Biosurfit
Astrego Diagnostics
Werfen
Abionic
Palex Medical/Bülhmann
Horiba Medical
RAL
Vircell
Monlab
Binding Site
Point-Of-Care Or Rapid Diagnostics segment by Type

Intensive Care
Covid-19 Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Others
Point-Of-Care Or Rapid Diagnostics segment by Application

Hospital
Clinic
Independent Laboratories
Others
Point-Of-Care Or Rapid Diagnostics segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-Of-Care Or Rapid Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Point-Of-Care Or Rapid Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-Of-Care Or Rapid Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Point-Of-Care Or Rapid Diagnostics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Point-Of-Care Or Rapid Diagnostics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Point-Of-Care Or Rapid Diagnostics sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Point-Of-Care Or Rapid Diagnostics Market by Type
1.2.1 Global Point-Of-Care Or Rapid Diagnostics Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Intensive Care
1.2.3 Covid-19 Testing
1.2.4 Infectious Diseases Testing
1.2.5 Cardiac Markers Testing
1.2.6 Coagulation Testing
1.2.7 Others
1.3 Point-Of-Care Or Rapid Diagnostics Market by Application
1.3.1 Global Point-Of-Care Or Rapid Diagnostics Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Independent Laboratories
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Point-Of-Care Or Rapid Diagnostics Market Dynamics
2.1 Point-Of-Care Or Rapid Diagnostics Industry Trends
2.2 Point-Of-Care Or Rapid Diagnostics Industry Drivers
2.3 Point-Of-Care Or Rapid Diagnostics Industry Opportunities and Challenges
2.4 Point-Of-Care Or Rapid Diagnostics Industry Restraints
3 Global Market Growth Prospects
3.1 Global Point-Of-Care Or Rapid Diagnostics Revenue Estimates and Forecasts (2019-2030)
3.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Region
3.2.1 Global Point-Of-Care Or Rapid Diagnostics Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Region (2019-2024)
3.2.3 Global Point-Of-Care Or Rapid Diagnostics Revenue by Region (2025-2030)
3.2.4 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Region (2019-2030)
3.3 Global Point-Of-Care Or Rapid Diagnostics Sales Estimates and Forecasts 2019-2030
3.4 Global Point-Of-Care Or Rapid Diagnostics Sales by Region
3.4.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Point-Of-Care Or Rapid Diagnostics Sales by Region (2019-2024)
3.4.3 Global Point-Of-Care Or Rapid Diagnostics Sales by Region (2025-2030)
3.4.4 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Point-Of-Care Or Rapid Diagnostics Revenue by Manufacturers
4.1.1 Global Point-Of-Care Or Rapid Diagnostics Revenue by Manufacturers (2019-2024)
4.1.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Point-Of-Care Or Rapid Diagnostics Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Point-Of-Care Or Rapid Diagnostics Sales by Manufacturers
4.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Manufacturers (2019-2024)
4.2.2 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Point-Of-Care Or Rapid Diagnostics Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Point-Of-Care Or Rapid Diagnostics Sales Price by Manufacturers (2019-2024)
4.4 Global Point-Of-Care Or Rapid Diagnostics Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Point-Of-Care Or Rapid Diagnostics Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Point-Of-Care Or Rapid Diagnostics Manufacturers, Product Type & Application
4.7 Global Point-Of-Care Or Rapid Diagnostics Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Point-Of-Care Or Rapid Diagnostics Market CR5 and HHI
4.8.2 2023 Point-Of-Care Or Rapid Diagnostics Tier 1, Tier 2, and Tier 3
5 Point-Of-Care Or Rapid Diagnostics Market by Type
5.1 Global Point-Of-Care Or Rapid Diagnostics Revenue by Type
5.1.1 Global Point-Of-Care Or Rapid Diagnostics Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2019-2030)
5.2 Global Point-Of-Care Or Rapid Diagnostics Sales by Type
5.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2019-2030) & (K Doses)
5.2.3 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2019-2030)
5.3 Global Point-Of-Care Or Rapid Diagnostics Price by Type
6 Point-Of-Care Or Rapid Diagnostics Market by Application
6.1 Global Point-Of-Care Or Rapid Diagnostics Revenue by Application
6.1.1 Global Point-Of-Care Or Rapid Diagnostics Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application (2019-2030)
6.2 Global Point-Of-Care Or Rapid Diagnostics Sales by Application
6.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2019-2030) & (K Doses)
6.2.3 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2019-2030)
6.3 Global Point-Of-Care Or Rapid Diagnostics Price by Application
7 Company Profiles
7.1 Roche
7.1.1 Roche Comapny Information
7.1.2 Roche Business Overview
7.1.3 Roche Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Roche Point-Of-Care Or Rapid Diagnostics Product Portfolio
7.1.5 Roche Recent Developments
7.2 Abbott
7.2.1 Abbott Comapny Information
7.2.2 Abbott Business Overview
7.2.3 Abbott Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Abbott Point-Of-Care Or Rapid Diagnostics Product Portfolio
7.2.5 Abbott Recent Developments
7.3 Danaher
7.3.1 Danaher Comapny Information
7.3.2 Danaher Business Overview
7.3.3 Danaher Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Danaher Point-Of-Care Or Rapid Diagnostics Product Portfolio
7.3.5 Danaher Recent Developments
7.4 Siemens Healthcare
7.4.1 Siemens Healthcare Comapny Information
7.4.2 Siemens Healthcare Business Overview
7.4.3 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product Portfolio
7.4.5 Siemens Healthcare Recent Developments
7.5 Bio-Rad Laboratories
7.5.1 Bio-Rad Laboratories Comapny Information
7.5.2 Bio-Rad Laboratories Business Overview
7.5.3 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product Portfolio
7.5.5 Bio-Rad Laboratories Recent Developments
7.6 BioMerieux
7.6.1 BioMerieux Comapny Information
7.6.2 BioMerieux Business Overview
7.6.3 BioMerieux Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 BioMerieux Point-Of-Care Or Rapid Diagnostics Product Portfolio
7.6.5 BioMerieux Recent Developments
7.7 Nova Biomedical
7.7.1 Nova Biomedical Comapny Information
7.7.2 Nova Biomedical Business Overview
7.7.3 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product Portfolio
7.7.5 Nova Biomedical Recent Developments
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Comapny Information
7.8.2 Thermo Fisher Scientific Business Overview
7.8.3 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product Portfolio
7.8.5 Thermo Fisher Scientific Recent Developments
7.9 Quidel
7.9.1 Quidel Comapny Information
7.9.2 Quidel Business Overview
7.9.3 Quidel Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Quidel Point-Of-Care Or Rapid Diagnostics Product Portfolio
7.9.5 Quidel Recent Developments
7.10 A. Menarini Diagnostics
7.10.1 A. Menarini Diagnostics Comapny Information
7.10.2 A. Menarini Diagnostics Business Overview
7.10.3 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio
7.10.5 A. Menarini Diagnostics Recent Developments
7.11 Becton Dickinson
7.11.1 Becton Dickinson Comapny Information
7.11.2 Becton Dickinson Business Overview
7.11.3 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product Portfolio
7.11.5 Becton Dickinson Recent Developments
7.12 Biosurfit
7.12.1 Biosurfit Comapny Information
7.12.2 Biosurfit Business Overview
7.12.3 Biosurfit Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Biosurfit Point-Of-Care Or Rapid Diagnostics Product Portfolio
7.12.5 Biosurfit Recent Developments
7.13 Astrego Diagnostics
7.13.1 Astrego Diagnostics Comapny Information
7.13.2 Astrego Diagnostics Business Overview
7.13.3 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio
7.13.5 Astrego Diagnostics Recent Developments
7.14 Werfen
7.14.1 Werfen Comapny Information
7.14.2 Werfen Business Overview
7.14.3 Werfen Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 Werfen Point-Of-Care Or Rapid Diagnostics Product Portfolio
7.14.5 Werfen Recent Developments
7.15 Abionic
7.15.1 Abionic Comapny Information
7.15.2 Abionic Business Overview
7.15.3 Abionic Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
7.15.4 Abionic Point-Of-Care Or Rapid Diagnostics Product Portfolio
7.15.5 Abionic Recent Developments
7.16 Palex Medical/Bülhmann
7.16.1 Palex Medical/Bülhmann Comapny Information
7.16.2 Palex Medical/Bülhmann Business Overview
7.16.3 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
7.16.4 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product Portfolio
7.16.5 Palex Medical/Bülhmann Recent Developments
7.17 Horiba Medical
7.17.1 Horiba Medical Comapny Information
7.17.2 Horiba Medical Business Overview
7.17.3 Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
7.17.4 Horiba Medical Point-Of-Care Or Rapid Diagnostics Product Portfolio
7.17.5 Horiba Medical Recent Developments
7.18 RAL
7.18.1 RAL Comapny Information
7.18.2 RAL Business Overview
7.18.3 RAL Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
7.18.4 RAL Point-Of-Care Or Rapid Diagnostics Product Portfolio
7.18.5 RAL Recent Developments
7.19 Vircell
7.19.1 Vircell Comapny Information
7.19.2 Vircell Business Overview
7.19.3 Vircell Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
7.19.4 Vircell Point-Of-Care Or Rapid Diagnostics Product Portfolio
7.19.5 Vircell Recent Developments
7.20 Monlab
7.20.1 Monlab Comapny Information
7.20.2 Monlab Business Overview
7.20.3 Monlab Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
7.20.4 Monlab Point-Of-Care Or Rapid Diagnostics Product Portfolio
7.20.5 Monlab Recent Developments
7.21 Binding Site
7.21.1 Binding Site Comapny Information
7.21.2 Binding Site Business Overview
7.21.3 Binding Site Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
7.21.4 Binding Site Point-Of-Care Or Rapid Diagnostics Product Portfolio
7.21.5 Binding Site Recent Developments
8 North America
8.1 North America Point-Of-Care Or Rapid Diagnostics Market Size by Type
8.1.1 North America Point-Of-Care Or Rapid Diagnostics Revenue by Type (2019-2030)
8.1.2 North America Point-Of-Care Or Rapid Diagnostics Sales by Type (2019-2030)
8.1.3 North America Point-Of-Care Or Rapid Diagnostics Price by Type (2019-2030)
8.2 North America Point-Of-Care Or Rapid Diagnostics Market Size by Application
8.2.1 North America Point-Of-Care Or Rapid Diagnostics Revenue by Application (2019-2030)
8.2.2 North America Point-Of-Care Or Rapid Diagnostics Sales by Application (2019-2030)
8.2.3 North America Point-Of-Care Or Rapid Diagnostics Price by Application (2019-2030)
8.3 North America Point-Of-Care Or Rapid Diagnostics Market Size by Country
8.3.1 North America Point-Of-Care Or Rapid Diagnostics Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Point-Of-Care Or Rapid Diagnostics Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Point-Of-Care Or Rapid Diagnostics Price by Country (2019-2030)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Point-Of-Care Or Rapid Diagnostics Market Size by Type
9.1.1 Europe Point-Of-Care Or Rapid Diagnostics Revenue by Type (2019-2030)
9.1.2 Europe Point-Of-Care Or Rapid Diagnostics Sales by Type (2019-2030)
9.1.3 Europe Point-Of-Care Or Rapid Diagnostics Price by Type (2019-2030)
9.2 Europe Point-Of-Care Or Rapid Diagnostics Market Size by Application
9.2.1 Europe Point-Of-Care Or Rapid Diagnostics Revenue by Application (2019-2030)
9.2.2 Europe Point-Of-Care Or Rapid Diagnostics Sales by Application (2019-2030)
9.2.3 Europe Point-Of-Care Or Rapid Diagnostics Price by Application (2019-2030)
9.3 Europe Point-Of-Care Or Rapid Diagnostics Market Size by Country
9.3.1 Europe Point-Of-Care Or Rapid Diagnostics Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Point-Of-Care Or Rapid Diagnostics Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
10 China
10.1 China Point-Of-Care Or Rapid Diagnostics Market Size by Type
10.1.1 China Point-Of-Care Or Rapid Diagnostics Revenue by Type (2019-2030)
10.1.2 China Point-Of-Care Or Rapid Diagnostics Sales by Type (2019-2030)
10.1.3 China Point-Of-Care Or Rapid Diagnostics Price by Type (2019-2030)
10.2 China Point-Of-Care Or Rapid Diagnostics Market Size by Application
10.2.1 China Point-Of-Care Or Rapid Diagnostics Revenue by Application (2019-2030)
10.2.2 China Point-Of-Care Or Rapid Diagnostics Sales by Application (2019-2030)
10.2.3 China Point-Of-Care Or Rapid Diagnostics Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Point-Of-Care Or Rapid Diagnostics Market Size by Type
11.1.1 Asia Point-Of-Care Or Rapid Diagnostics Revenue by Type (2019-2030)
11.1.2 Asia Point-Of-Care Or Rapid Diagnostics Sales by Type (2019-2030)
11.1.3 Asia Point-Of-Care Or Rapid Diagnostics Price by Type (2019-2030)
11.2 Asia Point-Of-Care Or Rapid Diagnostics Market Size by Application
11.2.1 Asia Point-Of-Care Or Rapid Diagnostics Revenue by Application (2019-2030)
11.2.2 Asia Point-Of-Care Or Rapid Diagnostics Sales by Application (2019-2030)
11.2.3 Asia Point-Of-Care Or Rapid Diagnostics Price by Application (2019-2030)
11.3 Asia Point-Of-Care Or Rapid Diagnostics Market Size by Country
11.3.1 Asia Point-Of-Care Or Rapid Diagnostics Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Point-Of-Care Or Rapid Diagnostics Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Point-Of-Care Or Rapid Diagnostics Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Point-Of-Care Or Rapid Diagnostics Market Size by Type
12.1.1 MEALA Point-Of-Care Or Rapid Diagnostics Revenue by Type (2019-2030)
12.1.2 MEALA Point-Of-Care Or Rapid Diagnostics Sales by Type (2019-2030)
12.1.3 MEALA Point-Of-Care Or Rapid Diagnostics Price by Type (2019-2030)
12.2 MEALA Point-Of-Care Or Rapid Diagnostics Market Size by Application
12.2.1 MEALA Point-Of-Care Or Rapid Diagnostics Revenue by Application (2019-2030)
12.2.2 MEALA Point-Of-Care Or Rapid Diagnostics Sales by Application (2019-2030)
12.2.3 MEALA Point-Of-Care Or Rapid Diagnostics Price by Application (2019-2030)
12.3 MEALA Point-Of-Care Or Rapid Diagnostics Market Size by Country
12.3.1 MEALA Point-Of-Care Or Rapid Diagnostics Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Point-Of-Care Or Rapid Diagnostics Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Point-Of-Care Or Rapid Diagnostics Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Point-Of-Care Or Rapid Diagnostics Value Chain Analysis
13.1.1 Point-Of-Care Or Rapid Diagnostics Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Point-Of-Care Or Rapid Diagnostics Production Mode & Process
13.2 Point-Of-Care Or Rapid Diagnostics Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Point-Of-Care Or Rapid Diagnostics Distributors
13.2.3 Point-Of-Care Or Rapid Diagnostics Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings